AlphaMark Advisors’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$23K Buy
1,459
+290
+25% +$5.14K 0.01% 339
2024
Q3
$22K Buy
1,169
+9
+0.8% +$168 0.01% 424
2024
Q2
$20K Hold
1,160
0.01% 454
2024
Q1
$20K Hold
1,160
0.01% 449
2023
Q4
$19K Hold
1,160
0.01% 453
2023
Q3
$18K Buy
1,160
+210
+22% +$3.5K 0.01% 443
2023
Q2
$16K Buy
950
+650
+217% +$11.3K 0.01% 346
2023
Q1
$5K Hold
300
﹤0.01% 495
2022
Q4
$5K Hold
300
﹤0.01% 449
2022
Q3
$5K Hold
300
﹤0.01% 506
2022
Q2
$6K Hold
300
﹤0.01% 450
2022
Q1
$6K Hold
300
﹤0.01% 452
2021
Q4
$7K Hold
300
﹤0.01% 428
2021
Q3
$8K Hold
300
﹤0.01% 427
2021
Q2
$8K Hold
300
﹤0.01% 423
2021
Q1
$7K Hold
300
﹤0.01% 417
2020
Q4
$7K Hold
300
﹤0.01% 400
2020
Q3
$6K Buy
+300
New +$6.34K ﹤0.01% 419

Other funds holding HQH

AlphaMark Advisors's HQH Position: Q4 2024 in Review

AlphaMark Advisors increased its abrdn Healthcare Investors (HQH) stake by 25% in Q4 2024, buying an estimated $5.14K and bringing the position to 1,459 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #339.

AlphaMark Advisors first reported a position in HQH in Q3 2020 and has held it in 18 quarters since. 120 funds tracked by Wall St. Rank hold HQH as of Q4 2024.

  • AlphaMark Advisors held 1,459 shares of abrdn Healthcare Investors worth $23K as of Q4 2024.
  • AlphaMark Advisors bought 290 abrdn Healthcare Investors shares in Q4 2024, an estimated $5.14K.
  • abrdn Healthcare Investors made up 0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #339 holding.
  • AlphaMark Advisors first reported a position in abrdn Healthcare Investors in Q3 2020 and has held it in 18 quarters since.
  • 120 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.